96 Participants Needed

Prosthetic Foot Adaptability for Amputation

Recruiting at 2 trial locations
MS
Overseen ByMonica Smersh
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Washington
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine how different designs of prosthetic feet can enhance daily life for individuals with lower extremity amputations. Participants will test both a locked and an unlocked version of a new foot prosthesis, the META-Arc foot, to evaluate which offers better comfort, mobility, and ease in daily activities. The study will compare these new designs to each participant's usual prosthetic foot. The trial seeks individuals who have had an amputation for at least one year, use a prosthesis, and can walk over 400 meters without increased pain. As an unphased trial, it offers participants the chance to contribute to innovative research that could advance prosthetic technology and improve quality of life for many.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on prosthetic foot use, so it's best to discuss your medications with the trial team.

What prior data suggests that this prosthetic foot is safe for people with lower extremity amputation?

Research has shown that the META-Arc prosthetic foot, in both its locked and unlocked versions, offers promising safety features based on mechanical testing. These tests revealed that the foot's design facilitates smooth side-to-side movement, which can reduce sideways forces and may lower the risk of falls or discomfort for users.

The META-Arc's ankle joint rotates side to side, similar to a natural human ankle, enhancing balance and comfort for individuals with lower-limb amputations. The locked version restricts this movement, providing a more stable option for those who need it.

Overall, studies suggest that both versions of the META-Arc foot enhance safety and comfort by reducing stress and increasing stability. However, as this is a new prosthetic foot, ongoing research and user feedback remain important to fully understand its safety in everyday use.12345

Why are researchers excited about this trial?

Researchers are excited about the META-Arc foot treatments because they offer innovative approaches to prosthetic foot adaptability for amputees. Unlike standard prosthetic feet, these treatments focus on adjustable ankle articulation, providing users with either locked or unlocked options. The unlocked condition allows for 20 degrees of frontal plane ankle motion, which could enhance natural movement and adaptability. Meanwhile, the locked condition eliminates this motion, potentially offering more stability. These options might lead to improved comfort and mobility for users, addressing varying needs in different situations.

What evidence suggests that the META-Arc foot is effective for improving mobility in people with lower extremity amputation?

Research has shown that the META-Arc prosthetic foot can improve balance and movement for people with leg amputations. In this trial, participants will join different arms to test the effectiveness of two versions of the META-Arc foot. The unlocked version, available to participants in one arm, allows for 20 degrees of movement, mimicking a natural ankle and reducing sideways pressure. This flexibility aids balance and eases walking. Meanwhile, the locked version, available to participants in another arm, limits side-to-side movement but still uses a special ankle joint to enhance stability. Both versions aim to make walking more comfortable and daily activities easier for users.12346

Who Is on the Research Team?

MM

Murray Maitland, PT, PhD

Principal Investigator

University of Washington

Are You a Good Fit for This Trial?

This trial is for individuals with above-knee amputations, bilateral amputations, or below-knee amputations who have lower mobility levels. It aims to help them with balance, pain, and daily activities by testing a new type of foot prosthesis.

Inclusion Criteria

I have been using a prosthesis for over a year since my amputation.
People must have the ability to read, write, and comprehend English.
I can walk more than 400 meters without feeling more pain.
See 4 more

Exclusion Criteria

Participants must not have conditions such as skin wounds that preclude the use of a prosthesis.
I do not have conditions like Parkinson's, alcoholism, brain tumor, or hereditary cerebellar ataxias that could affect my walking.
I can walk with help but don't mainly use a wheelchair.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

A1 Phase

Participants use their usual prosthetic foot and complete baseline assessments

2 weeks
1 visit (in-person)

B1 Phase

Participants use the investigational foot with either locked or unlocked linkage and perform community activities

2 weeks
1 visit (in-person), daily logbook entries

B2 Phase

Participants continue using the investigational foot with the opposite linkage condition and perform community activities

2 weeks
1 visit (in-person), daily logbook entries

A2 Phase

Participants return to using their usual prosthetic foot and reflect on differences

2 weeks
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the trial phases

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • META-Arc foot locked
  • META-Arc foot unlocked
Trial Overview The study tests a novel foot prosthesis in two modes: locked and unlocked. Participants will be randomly assigned to use either mode and their usual prosthetic foot to compare performance, comfort, and mobility.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Unlocked ankle articulationExperimental Treatment1 Intervention
Group II: Locked ankle articulationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Washington

Lead Sponsor

Trials
1,858
Recruited
2,023,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Published Research Related to This Trial

The META Arc prosthetic foot, featuring a polycentric ankle joint, significantly improves adaptability in the frontal plane and reduces lateral forces compared to six other commercially available prosthetic feet during testing on uneven terrain.
This design allows for better stability while walking without compromising forward motion performance, suggesting it could enhance the overall mobility of prosthesis users.
Mechanical testing of frontal plane adaptability of commercially available prosthetic feet.Wernke, MM., Ficanha, EM., Thomas, Z., et al.[2022]
A study involving 10 individuals with unilateral transtibial amputation found that a novel 3D-printed prosthetic foot (ComfyStep) showed significant biomechanical differences compared to conventional prosthetic feet, including reduced range of motion and increased stiffness.
While the 3D-printed foot allows for more individualized adjustments, the differences observed raise questions about its clinical relevance, suggesting that improvements in design, particularly in stiffness, could enhance its performance.
Biomechanical comparison of a 3D-printed prosthetic foot with conventional feet in people with transtibial amputation: A prospective cohort study.Trinler, U., Heitzmann, DWW., Hitzeroth, S., et al.[2023]
Older adults with lower limb amputation reported significant adjustments in their lives post-amputation, highlighting the long-term impact of this experience.
Participants using the self-aligning ankle-foot (SA-AF) prosthetic reported less pain and greater mobility, indicating its acceptability and effectiveness, which supports the need for further research in a full-scale randomized controlled trial.
'A whole different ball game': the qualitative experience of older adults with a transtibial amputation and the use of a self-aligning prosthetic ankle-foot on the STEPFORWARD trial.Mitchell, N., Leggett, H., Watson, J., et al.[2023]

Citations

Mechanical testing of frontal plane adaptability ...The results found the META Arc prosthetic foot had increased frontal plane adaptability as well as reduced lateral forces, and reduced inversion eversion ...
The META Arc foot with a polycentric ankle joint that rotates ...A new prosthetic foot, the META Arc, was designed with a polycentric ankle joint that allows relatively free movement in the frontal plane to address this ...
Effectiveness of Frontal Plane Adaptability in a Novel Fo...Participants are provided with the META-Arc from WIllowWood Global, and a locking mechanism prevents side-to-side motion. 2. META-Arc foot ...
Motion Analysis of a Frontal Plane Adaptable Prosthetic FootThe study hypothesizes that conditions resulting in increased frontal plane motion for control participants would be more likely to be achieved by an adaptable ...
Modeling and simulation of a multi-axis ankle foot ...Abstract This study investigates how to design and analyze a multi-axis prosthetic foot that replicates human foot movement characteristics.
(PDF) Mechanical testing of frontal plane adaptability of ...Results The results found the META Arc prosthetic foot had increased frontal plane adaptability as well as reduced lateral forces, and reduced inversion ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security